As expected, unstimulated normal human T cells appeared to be significantly less sensitive to BS-181 cytotoxicity than malignant tumor cells (Jurkat A3, U937, and HeLa), whereas the sensitivity of IL-2-dependent proliferation of PHA-stimulated normal T cells was somewhat close to those of the malignant cells when treated with BS-181 at concentrations above 15 μM. Here, IL2 is linked to cancer.